美国多学会组发布锯齿状息肉病综合征诊断与管理共识
New recommendations for serrated polyposis syndrome
美国结直肠癌多学会任务组(MSTF)发布11项循证建议,指出锯齿状息肉病综合征(SPS)是最常见的胃肠道息肉综合征但常未被识别。建议采用2019年世界卫生组织标准诊断SPS,无并发结直肠癌者优先推荐内镜治疗而非手术,并规定清肠结肠镜检查间隔3至6个月,后续监测间隔1至2年。
共识明确SPS诊断标准及内镜治疗优先原则,为临床降低结直肠癌风险提供可操作路径。
New consensus recommendations by the U.S. Multi-Society Task Force (MSTF) on Colorectal Cancer (CRC) address serrated polyposis syndrome (SPS), which is the most common gastrointestinal polyp syndrome yet is widely underrecognized and often goes undiagnosed. SPS is a clinical syndrome characterized by an increased number of serrated lesions and is associated with an increased risk of CRC.
The MSTF offers 11 evidence-based recommendations to increase awareness and identification of SPS among gastroenterologists and surgical endoscopists. It also offers clinical strategies for improving SPS diagnosis, surgical and endoscopic management, CRC risk assessment and surveillance intervals, and genetic risk assessment.
"These recommendations emphasize recognition of the syndrome, including by tracking numbers of serrated polyps over multiple colonoscopies. Best practices are also described for identification of serrated lesions during colonoscopy, as well as endoscopic resection of serrated lesions and surveillance of serrated polyposis patients," said lead author Douglas K. Rex, M.D., MACP, MACG, MASGE, AGAF.
The task force is charged with developing recommendations for best practices for CRC screening and surveillance and the general prevention of CRC. It is composed of representatives from the American College of Gastroenterology, American Gastroenterological Association and the American Society for Gastrointestinal Endoscopy.
The consensus document is published in the American Journal of Gastroenterology.
"This set of clinical recommendations addresses the major issues related to identification and diagnosis of SPS in patients and affected relatives as well as management of SPS," the authors write.
Recommendations from the MSTF
Improving SPS diagnosis
- The MSTF recommends that the 2019 World Health Organization criteria be used for diagnosis of SPS. These criteria include the size, cumulative lifetime number and location of serrated polyps throughout the colon.
- When multiple serrated polyps are detected during colonoscopy, the authors recommend detailing the number, size and location in the procedure report and continuing to do so at least until an SPS diagnosis is established.
- The task force recommends colonoscopy in SPS be performed by endoscopists with documented adequate detection of sessile serrated lesions during routine colonoscopy, and with high-definition white light colonoscopy with or without virtual or dye spray chromoendoscopy.
SPS management
- In patients without concurrent CRC, the authors recommend endoscopy as the preferred strategy over surgery for primary management of SPS.
- For individuals with SPS whose polyp burden is deemed endoscopically unmanageable, the MSTF suggests referral to an advanced endoscopic resection expert before surgical resection.
- In SPS patients, the group recommends that SSLs and hyperplastic polyps be resected by cold snare—with or without submucosal injection for larger lesions—except when dysplastic areas are endoscopically evident.
CRC risk in SPS and surveillance intervals
- The task force recommends clearance colonoscopy at a three- to six-month interval, followed by a one- to two-year surveillance phase.
- In patients with greatly reduced polyp burdens at surveillance, the authors suggest that three-year intervals can be considered
Genetic risk assessment
- SPS lacks an established genetic basis. The MSTF recommends that germline genetic testing in patients with diagnosed SPS be performed only when there are concurrent nonserrated polyps that may indicate that genetic testing is warranted.
- The authors suggest first-degree relatives of individuals with SPS undergo colonoscopy at age 40, 10 years before the youngest age at CRC diagnosis, or five years before the youngest age at SPS diagnosis in the family, whichever is earlier.
Publication details
Douglas K. Rex et al, Serrated Polyposis Syndrome: A Review and Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer, American Journal of Gastroenterology (2026). DOI: 10.14309/ajg.0000000000004081
Journal information: American Journal of Gastroenterology
Provided by American College of Gastroenterology
Who's behind this story?
Sadie Harley
BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →
Alexander Pol
PhD nano-engineering from Delft University. Published researcher and journal reviewer. Brings scientific insight to content standards. Full profile →
Citation: New recommendations for serrated polyposis syndrome (2026, October 1) retrieved 1 October 2026 from https://medicalxpress.com/news/2026-10-serrated-polyposis-syndrome.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com